4//SEC Filing
Bancroft Robert E. 4
Accession 0001610717-25-000111
CIK 0001837607other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:50 PM ET
Size
5.3 KB
Accession
0001610717-25-000111
Insider Transaction Report
Form 4
Bancroft Robert E.
DirectorPresident & CEO
Transactions
- Award
Stock Option
2025-04-29+59,034→ 59,034 totalExercise: $0.41Exp: 2035-04-29→ Class A Common Stock (59,034 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on each anniversary measured from April 29, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
AEON Biopharma, Inc.
CIK 0001837607
Entity typeother
Related Parties
1- filerCIK 0002066370
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:50 PM ET
- Size
- 5.3 KB